Article and Video CATEGORIES

Cancer Journey

Search By

Choices Among Immunotherapeutics May Be the Future of Lung Cancer Care
Author
GRACE Videos and Articles

ASCO 2015 Highlights 03

 

Novel immunotherapy agent atezolizumab (MPDL3280A) looks superior to Taxotere (docetaxel) in a study, specifically for patients with PD-L1. What are the implications of multiple agents with similar mechanisms of action in the same clinical settings?

[powerpress]

Download Transcript

Please feel free to offer comments and raise questions in our Discussion Forums.

 

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora

Forum Discussions

I don't know what to do. No insurance

Hi Ascardino, Welcome to Grace. I'm so sorry to hear of your situation.  While we don't have specific info or expertise on ovarian cancer, I did some searching for information.  It...

Hello Janine,

Thank you for sharing this valuable leukemia playlist—building a reliable knowledge base like this truly makes a difference for everyone navigating such a challenging journey. I appreciate the open...

Recent Comments

JOIN THE CONVERSATION
New Leukemia Playlist Summer 2025
By Maxey21 on
Hi Ascardino, Welcome to…
By JanineT GRACE … on
I don't know what to do. No…
By Ascardino on
Hi Hopish hope,  Welcome to…
By JanineT GRACE … on